Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Olfaction Disorders | 30 | 2021 | 3704 | 4.04 | Why? |
| Smell | 16 | 2021 | 1851 | 1.88 | Why? |
| Rhinitis | 8 | 2019 | 626 | 1.79 | Why? |
| Sinusitis | 8 | 2019 | 649 | 1.74 | Why? |
| Taste Disorders | 10 | 2021 | 1720 | 1.40 | Why? |
| Dysgeusia | 3 | 2020 | 524 | 1.16 | Why? |
| Taste | 5 | 2021 | 715 | 0.93 | Why? |
| Nasal Polyps | 2 | 2019 | 221 | 0.77 | Why? |
| Neuropilin-1 | 1 | 2020 | 284 | 0.69 | Why? |
| Epistaxis | 1 | 2017 | 96 | 0.64 | Why? |
| Peer Review, Research | 1 | 2021 | 407 | 0.64 | Why? |
| Medical Audit | 1 | 2017 | 218 | 0.63 | Why? |
| Endpoint Determination | 1 | 2017 | 344 | 0.58 | Why? |
| Patient Outcome Assessment | 1 | 2017 | 707 | 0.49 | Why? |
| Publishing | 1 | 2021 | 990 | 0.42 | Why? |
| Consensus | 2 | 2020 | 6345 | 0.36 | Why? |
| Outpatients | 1 | 2020 | 3417 | 0.33 | Why? |
| Glucocorticoids | 2 | 2021 | 4431 | 0.33 | Why? |
| Models, Biological | 1 | 2020 | 4907 | 0.25 | Why? |
| Nasal Lavage | 2 | 2021 | 91 | 0.25 | Why? |
| Disease Management | 1 | 2020 | 6841 | 0.24 | Why? |
| Nasal Decongestants | 1 | 2021 | 8 | 0.24 | Why? |
| Nasal Obstruction | 2 | 2020 | 131 | 0.23 | Why? |
| Pneumonia, Viral | 14 | 2020 | 243684 | 0.23 | Why? |
| Self Report | 4 | 2021 | 3802 | 0.23 | Why? |
| Coronavirus Infections | 14 | 2020 | 253789 | 0.22 | Why? |
| Mometasone Furoate | 1 | 2021 | 37 | 0.22 | Why? |
| Expectorants | 1 | 2021 | 95 | 0.22 | Why? |
| Psychophysics | 1 | 2021 | 56 | 0.22 | Why? |
| Research Design | 1 | 2017 | 5830 | 0.21 | Why? |
| Olfactory Receptor Neurons | 1 | 2020 | 110 | 0.21 | Why? |
| Respiratory Tract Infections | 1 | 2020 | 6817 | 0.19 | Why? |
| Sensory Thresholds | 1 | 2020 | 115 | 0.19 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2018 | 10649 | 0.19 | Why? |
| Administration, Intranasal | 2 | 2021 | 1132 | 0.18 | Why? |
| Therapeutic Irrigation | 1 | 2019 | 167 | 0.18 | Why? |
| Chronic Disease | 5 | 2019 | 5139 | 0.18 | Why? |
| Humans | 43 | 2021 | 930598 | 0.17 | Why? |
| Fluconazole | 1 | 2018 | 145 | 0.17 | Why? |
| Olfactory Mucosa | 1 | 2020 | 372 | 0.17 | Why? |
| Olfactory Bulb | 1 | 2020 | 333 | 0.17 | Why? |
| Pandemics | 16 | 2020 | 389249 | 0.16 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.16 | Why? |
| Amphotericin B | 1 | 2018 | 256 | 0.16 | Why? |
| Prevalence | 8 | 2021 | 25773 | 0.15 | Why? |
| Betacoronavirus | 14 | 2020 | 204454 | 0.15 | Why? |
| Diagnosis, Differential | 2 | 2020 | 7220 | 0.14 | Why? |
| Prospective Studies | 9 | 2021 | 43301 | 0.14 | Why? |
| T-Lymphocytes, Regulatory | 1 | 2020 | 698 | 0.14 | Why? |
| Phytotherapy | 1 | 2021 | 743 | 0.14 | Why? |
| Crowdsourcing | 1 | 2017 | 258 | 0.13 | Why? |
| Ageusia | 1 | 2021 | 918 | 0.13 | Why? |
| Nasal Mucosa | 1 | 2020 | 1218 | 0.12 | Why? |
| Search Engine | 1 | 2020 | 628 | 0.12 | Why? |
| Drug Hypersensitivity | 1 | 2018 | 401 | 0.12 | Why? |
| Patient-Centered Care | 1 | 2020 | 860 | 0.11 | Why? |
| Severity of Illness Index | 5 | 2021 | 48226 | 0.10 | Why? |
| Male | 16 | 2021 | 367725 | 0.10 | Why? |
| Viral Load | 2 | 2021 | 15850 | 0.10 | Why? |
| Aspirin | 1 | 2018 | 1043 | 0.10 | Why? |
| Headache | 1 | 2020 | 2257 | 0.10 | Why? |
| Surveys and Questionnaires | 6 | 2020 | 43792 | 0.09 | Why? |
| Asthma | 2 | 2018 | 4383 | 0.09 | Why? |
| Odorants | 2 | 2021 | 219 | 0.09 | Why? |
| Climate Change | 1 | 2017 | 901 | 0.09 | Why? |
| Endoscopy | 1 | 2019 | 1564 | 0.09 | Why? |
| Female | 15 | 2021 | 380317 | 0.09 | Why? |
| Middle Aged | 13 | 2021 | 270681 | 0.09 | Why? |
| Internationality | 1 | 2021 | 3297 | 0.09 | Why? |
| Antifungal Agents | 1 | 2018 | 1828 | 0.09 | Why? |
| Sleep Wake Disorders | 1 | 2018 | 1463 | 0.08 | Why? |
| Adult | 12 | 2021 | 244371 | 0.08 | Why? |
| Family | 1 | 2020 | 2909 | 0.08 | Why? |
| Bias | 2 | 2021 | 1109 | 0.07 | Why? |
| Cross-Sectional Studies | 4 | 2020 | 53120 | 0.07 | Why? |
| Software | 1 | 2017 | 2501 | 0.07 | Why? |
| Population Surveillance | 2 | 2020 | 4967 | 0.07 | Why? |
| Clinical Laboratory Techniques | 3 | 2020 | 23402 | 0.07 | Why? |
| Information Dissemination | 1 | 2021 | 2986 | 0.07 | Why? |
| Smoking | 1 | 2018 | 3358 | 0.07 | Why? |
| Guideline Adherence | 1 | 2017 | 2309 | 0.07 | Why? |
| Referral and Consultation | 1 | 2020 | 4816 | 0.07 | Why? |
| Adrenal Cortex Hormones | 1 | 2021 | 6537 | 0.07 | Why? |
| Magnetic Resonance Imaging | 1 | 2020 | 6551 | 0.07 | Why? |
| United Kingdom | 3 | 2020 | 18046 | 0.06 | Why? |
| Aged | 7 | 2021 | 215776 | 0.06 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 13720 | 0.06 | Why? |
| Young Adult | 4 | 2020 | 93724 | 0.06 | Why? |
| Syzygium | 1 | 2021 | 12 | 0.06 | Why? |
| Primary Health Care | 1 | 2020 | 4839 | 0.06 | Why? |
| Prognosis | 3 | 2020 | 32490 | 0.06 | Why? |
| Algorithms | 1 | 2019 | 7346 | 0.06 | Why? |
| Citrus | 1 | 2021 | 29 | 0.06 | Why? |
| Ambroxol | 1 | 2021 | 45 | 0.06 | Why? |
| Betamethasone | 1 | 2021 | 63 | 0.06 | Why? |
| Virus Internalization | 1 | 2020 | 7921 | 0.06 | Why? |
| Visual Analog Scale | 1 | 2021 | 151 | 0.06 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 3832 | 0.05 | Why? |
| Recovery of Function | 2 | 2021 | 2461 | 0.05 | Why? |
| Physical Stimulation | 1 | 2020 | 42 | 0.05 | Why? |
| Quality of Life | 3 | 2021 | 9820 | 0.05 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.05 | Why? |
| Diagnostic Techniques, Respiratory System | 1 | 2020 | 114 | 0.05 | Why? |
| Cohort Studies | 2 | 2020 | 36005 | 0.05 | Why? |
| Italy | 2 | 2020 | 38444 | 0.05 | Why? |
| Confidence Intervals | 1 | 2021 | 744 | 0.05 | Why? |
| Flowers | 1 | 2017 | 31 | 0.04 | Why? |
| Administration, Topical | 1 | 2018 | 272 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2019 | 10083 | 0.04 | Why? |
| Prednisone | 1 | 2021 | 652 | 0.04 | Why? |
| Statistics as Topic | 1 | 2018 | 370 | 0.04 | Why? |
| Forced Expiratory Volume | 1 | 2018 | 632 | 0.04 | Why? |
| Predictive Value of Tests | 2 | 2020 | 9537 | 0.04 | Why? |
| Eosinophilia | 1 | 2018 | 292 | 0.03 | Why? |
| Myalgia | 1 | 2020 | 1015 | 0.03 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.03 | Why? |
| Patient Reported Outcome Measures | 1 | 2020 | 912 | 0.03 | Why? |
| Administration, Oral | 1 | 2021 | 2340 | 0.03 | Why? |
| Belgium | 1 | 2020 | 2064 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.03 | Why? |
| Europe | 2 | 2020 | 12702 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.03 | Why? |
| Ventilation | 1 | 2020 | 1145 | 0.03 | Why? |
| Translating | 1 | 2012 | 80 | 0.03 | Why? |
| Self Care | 1 | 2020 | 918 | 0.03 | Why? |
| Administration, Inhalation | 1 | 2018 | 1647 | 0.03 | Why? |
| Cultural Characteristics | 1 | 2012 | 159 | 0.03 | Why? |
| Child | 1 | 2020 | 70012 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.03 | Why? |
| Bayes Theorem | 1 | 2020 | 3237 | 0.03 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.03 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.03 | Why? |
| Case-Control Studies | 2 | 2020 | 17671 | 0.03 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.02 | Why? |
| Cluster Analysis | 1 | 2018 | 3001 | 0.02 | Why? |
| Brazil | 2 | 2018 | 12582 | 0.02 | Why? |
| Iran | 1 | 2020 | 5467 | 0.02 | Why? |
| Language | 1 | 2012 | 655 | 0.02 | Why? |
| Disinfection | 1 | 2020 | 2912 | 0.02 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.02 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.02 | Why? |
| Psychometrics | 1 | 2012 | 1269 | 0.02 | Why? |
| Interleukin-6 | 1 | 2021 | 7522 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Virus Diseases | 1 | 2020 | 3779 | 0.02 | Why? |
| United States | 2 | 2020 | 46150 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2020 | 22971 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.01 | Why? |
| Lung | 1 | 2021 | 31049 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
| Risk Factors | 1 | 2018 | 71621 | 0.01 | Why? |
Hopkins's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(154)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(189)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_